These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 17688172

  • 1. Biochemical markers, extracellular components in liver fibrosis and cirrhosis.
    Bolarin DM, Azinge EC.
    Nig Q J Hosp Med; 2007; 17(1):42-52. PubMed ID: 17688172
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Connective tissue polypeptides in serum as parameters to monitor antifibrotic treatment in hepatic fibrogenesis.
    Schuppan D.
    J Hepatol; 1991; 13 Suppl 3():S17-25. PubMed ID: 1815006
    [Abstract] [Full Text] [Related]

  • 4. Hepatic fibrosis and its serum markers: a review.
    Gabrielli GB, Corrocher R.
    Dig Dis; 1991; 9(5):303-16. PubMed ID: 1752069
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Biochemical markers of hepatic fibrosis.
    Plebani M, Burlina A.
    Clin Biochem; 1991 Jun; 24(3):219-39. PubMed ID: 1651819
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology.
    Murawaki Y, Ikuta Y, Koda M, Kawasaki H.
    Hepatology; 1994 Oct; 20(4 Pt 1):780-7. PubMed ID: 7927217
    [Abstract] [Full Text] [Related]

  • 12. Collagen breakdown products as markers of fibrosis and cirrhosis.
    Niemelä O.
    Alcohol Alcohol Suppl; 1994 Oct; 2():345-52. PubMed ID: 8974354
    [Abstract] [Full Text] [Related]

  • 13. Sequential behaviour of extracellular matrix glycoproteins in an experimental model of hepatic fibrosis.
    Ballardini G, Faccani A, Fallani M, Berti S, Vasi V, Castaldini C, Biagini G, Garbisa S, Bianchi FB.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1985 Oct; 49(4):317-24. PubMed ID: 2867632
    [Abstract] [Full Text] [Related]

  • 14. Serum carboxy terminal propeptide of type I procollagen to amino terminal propeptide of type III procollagen ratio is a better indicator than each single propeptide and 7S domain type IV collagen for progressive fibrogenesis in chronic viral liver diseases.
    Lin DY, Chu CM, Sheen IS, Liaw YF.
    Dig Dis Sci; 1995 Jan; 40(1):21-7. PubMed ID: 7821112
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Biochemical markers of hepatic fibrosis in primary biliary cirrhosis.
    Plebani M, Giacomini A, Floreani A, Chiaramonte M, Soffiati G, Naccarato R, Burlina A.
    Ric Clin Lab; 1990 Jan; 20(4):269-74. PubMed ID: 2075379
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.